Michael Fehlings
Overview
Explore the profile of Michael Fehlings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
3526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmidt F, Wu K, Gerber L, Chioh Wen Jing F, Pedrosa D, Wong Choon Lim G, et al.
Bioinform Adv
. 2025 Mar;
5(1):vbaf037.
PMID: 40083714
Summary: The exogenous, i.e. , loading of peptides onto major histocompatibility complex (MHC) class I molecules is a key step in many immunology-related experimental workflows. Here, we provide a machine...
2.
Cao C, Sang J, Arora R, Chen D, Kloosterman R, Cecere M, et al.
Ann Intern Med
. 2025 Feb;
PMID: 39993313
Background: Systematic reviews (SRs) are hindered by the initial rigorous article screen, which delays access to reliable information synthesis. Objective: To develop generic prompt templates for large language model (LLM)-driven...
3.
Al-Zakri M, Eren A, Cahill P, Jaakkimainen L, To T, Bouchard M, et al.
Can J Surg
. 2024 Nov;
67(6suppl1):S17-S76.
PMID: 39537311
No abstract available.
4.
Ranjbar Hameghavandi M, Khodadoust E, Hassan Zadeh Tabatabaei M, Farahbakhsh F, Ghodsi Z, Rostamkhani S, et al.
Front Public Health
. 2024 Sep;
12:1377513.
PMID: 39224559
Objective: To evaluate the leading challenges in developing countries' traumatic spinal cord injury (TSCI) care. Methods: We conducted a systematic search in electronic databases of PubMed, SCOPUS, Web of Science,...
5.
Terrapon A, Stienen M, Veeravagu A, Fehlings M, Bozinov O, Hejrati N
Brain Spine
. 2024 Jul;
4:102843.
PMID: 38947985
Introduction: Cystic schwannomas have only been reported in a few case reports/series. As a result, they may be misdiagnosed and a standardized management approach remains challenging to establish. Research Question:...
6.
Wolz O, Vahrenhorst D, Quintini G, Lemberg C, Koch S, Kays S, et al.
Vaccines (Basel)
. 2024 Apr;
12(4).
PMID: 38675770
Vaccines are highly effective at preventing severe coronavirus disease (COVID-19). With mRNA vaccines, further research is needed to understand the association between immunogenicity and reactogenicity, which is defined as the...
7.
Feola S, Chiaro J, Fusciello M, Russo S, Kleino I, Ylosmaki L, et al.
Int J Biol Macromol
. 2024 Feb;
262(Pt 1):129926.
PMID: 38331062
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) posed a threat to public health and the global economy, necessitating the development of various vaccination strategies. Mutations in the...
8.
Mimura K, Ogata T, Nguyen P, Roy S, Kared H, Yuan Y, et al.
J Immunother Cancer
. 2024 Jan;
12(1).
PMID: 38290769
Background: Tumor-associated antigen (TAA)-specific CD8(+) T cells are essential for nivolumab therapy, and irradiation has been reported to have the potential to generate and activate TAA-specific CD8(+) T cells. However,...
9.
Ojeda J, Vergara M, Avila A, Henriquez J, Fehlings M, Vidal P
Front Cell Neurosci
. 2024 Jan;
17:1316432.
PMID: 38269114
Degenerative Cervical Myelopathy (DCM) is a progressive neurological condition characterized by structural alterations in the cervical spine, resulting in compression of the spinal cord. While clinical manifestations of DCM are...
10.
Tan J, Tay T, Ong E, Fehlings M, Tan D, Sukma N, et al.
Eur Thyroid J
. 2024 Jan;
PMID: 38181007
Objectives Anaplastic thyroid cancer (ATC) is an aggressive disease associated with poor outcomes and resistance to therapies. Our study aim was to evaluate the activity of a combinatorial regimen of...